510(k) K183160

TEG 6s Hemostasis System, TEG 6s Citrated: K, RT, FF Assay Cartridge by Haemonetics Corporation — Product Code JPA

K183160 is an FDA 510(k) premarket notification submitted by Haemonetics Corporation for the device "TEG 6s Hemostasis System, TEG 6s Citrated: K, RT, FF Assay Cartridge". The FDA issued a decision of Substantially Equivalent on May 9, 2019. The device falls under product code JPA (System, Multipurpose For In Vitro Coagulation Studies), a Class II device regulated under 21 CFR 864.5425. Haemonetics Corporation has at least 6 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 9, 2019
Date Received
November 15, 2018
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Multipurpose For In Vitro Coagulation Studies
Device Class
Class II
Regulation Number
864.5425
Review Panel
HE
Submission Type